Patients with various cancers, including breast, gastrointestinal, liver, prostate, brain, endometrial, and lung cancers, as well as astrocytoma and glioblastoma, have elevated levels of CHI3L1(YKL40) in their serum [3,10,11,12]. Here, CHI3L1 is linked to lung carcinoma.